Nrf2 protects against maladaptive cardiac responses to hemodynamic stress
- PMID: 19592468
- DOI: 10.1161/ATVBAHA.109.189480
Nrf2 protects against maladaptive cardiac responses to hemodynamic stress
Abstract
Background: Reactive oxygen species (ROS) play an important role in the maintenance of cardiovascular homeostasis. The present study sought to determine whether nuclear factor erythroid-2 related factor 2 (Nrf2), a master gene of the endogenous antioxidant defense system, is a critical regulator of the cardiac hypertrophic response to pathological stress.
Methods and results: Cardiac hypertrophy and dysfunction were established in mice by transverse aortic constriction (TAC). Nrf2 expression was transiently increased and then declined to the basal level while impairment of cardiac function proceeded. The knockout of Nrf2 (Nrf2(-/-)) did not cause any apparent structural and functional abnormalities in the unstressed heart. However, Nrf2(-/-) mice after TAC developed pathological cardiac hypertrophy, significant myocardial fibrosis and apoptosis, overt heart failure, and increased mortality, which were associated with elevated myocardial levels of 4-hydroxy-2-nonenal and 8-hydroxydeoxyguanosine and a complete blockade of the myocardial expression of several antioxidant genes. Overexpression of Nrf2 dramatically inhibited hypertrophic factor-induced ROS production and growth in both cardiomyocytes and cardiac fibroblasts, whereas knockdown of Nrf2 exerted opposite effects in both cells.
Conclusions: These findings demonstrate that activation of Nrf2 provides a novel mechanism to protect the murine heart against pathological cardiac hypertrophy and heart failure via suppressing oxidative stress.
Similar articles
-
Deubiquitinating enzyme CYLD mediates pressure overload-induced cardiac maladaptive remodeling and dysfunction via downregulating Nrf2.J Mol Cell Cardiol. 2015 Jul;84:143-53. doi: 10.1016/j.yjmcc.2015.04.012. Epub 2015 Apr 30. J Mol Cell Cardiol. 2015. PMID: 25935309
-
Nrf2-Mediated Cardiac Maladaptive Remodeling and Dysfunction in a Setting of Autophagy Insufficiency.Hypertension. 2016 Jan;67(1):107-17. doi: 10.1161/HYPERTENSIONAHA.115.06062. Epub 2015 Nov 16. Hypertension. 2016. PMID: 26573705 Free PMC article.
-
Nrf2 enhances myocardial clearance of toxic ubiquitinated proteins.J Mol Cell Cardiol. 2014 Jul;72:305-15. doi: 10.1016/j.yjmcc.2014.04.006. Epub 2014 Apr 18. J Mol Cell Cardiol. 2014. PMID: 24747945 Free PMC article.
-
NRF2 in Cardiovascular Diseases: a Ray of Hope!J Cardiovasc Transl Res. 2021 Jun;14(3):573-586. doi: 10.1007/s12265-020-10083-8. Epub 2020 Nov 25. J Cardiovasc Transl Res. 2021. PMID: 33241490 Review.
-
The role of Nrf2-mediated pathway in cardiac remodeling and heart failure.Oxid Med Cell Longev. 2014;2014:260429. doi: 10.1155/2014/260429. Epub 2014 Jul 1. Oxid Med Cell Longev. 2014. PMID: 25101151 Free PMC article. Review.
Cited by
-
A pro-inflammatory role of deubiquitinating enzyme cylindromatosis (CYLD) in vascular smooth muscle cells.Biochem Biophys Res Commun. 2012 Mar 30;420(1):78-83. doi: 10.1016/j.bbrc.2012.02.118. Epub 2012 Mar 1. Biochem Biophys Res Commun. 2012. PMID: 22406061 Free PMC article.
-
The Role of NRF2 in Obesity-Associated Cardiovascular Risk Factors.Antioxidants (Basel). 2022 Jan 26;11(2):235. doi: 10.3390/antiox11020235. Antioxidants (Basel). 2022. PMID: 35204118 Free PMC article. Review.
-
Mitochondria as a source and target of lipid peroxidation products in healthy and diseased heart.Clin Exp Pharmacol Physiol. 2012 Feb;39(2):179-93. doi: 10.1111/j.1440-1681.2011.05641.x. Clin Exp Pharmacol Physiol. 2012. PMID: 22066679 Free PMC article. Review.
-
Nrf2-Keap1 in Cardiovascular Disease: Which Is the Cart and Which the Horse?Physiology (Bethesda). 2024 Sep 1;39(5):0. doi: 10.1152/physiol.00015.2024. Epub 2024 Apr 30. Physiology (Bethesda). 2024. PMID: 38687468 Review.
-
Tert-butylhydroquinone lowers blood pressure in AngII-induced hypertension in mice via proteasome-PTEN-Akt-eNOS pathway.Sci Rep. 2016 Jul 20;6:29589. doi: 10.1038/srep29589. Sci Rep. 2016. Retraction in: Sci Rep. 2019 Nov 19;9(1):17122. doi: 10.1038/s41598-019-53022-7 PMID: 27435826 Free PMC article. Retracted.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
